Alere Inc. is a listed company. Filings by its managers are published through SEC (Form 4). No insider at Alere Inc. has published a filing in the past twelve months. The most recent one dates from 3 October 2017.
Looking back to 2016, when coverage begins, insiders filed no purchases and 3 sales.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2016 · cache
25 of 143 declarations
Alere Inc. is a company specializing in medical diagnostics, providing solutions for the detection and management of diseases. It is listed on the XNAS market.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2016 | 2.38 bn USD | -137.6 m USD | n.d. | 10-K |
| Dec 2015 | 2.46 bn USD | 203.7 m USD | n.d. | 10-K |
| Dec 2014 | 2.58 bn USD | -33.2 m USD | n.d. | 10-K |
| Dec 2013 | 2.61 bn USD | -75.0 m USD | n.d. | 10-K |
| Dec 2012 | 2.39 bn USD | -78.5 m USD | n.d. | 10-K/A |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.